» Articles » PMID: 34457305

Clinically Unsuspected Primary Hepatic Mucosa-associated Lymphoid Tissue Lymphoma Collision with an Intrahepatic Cholangiocarcinoma: A Case Report and Literature Review

Overview
Publisher Sage Publications
Specialty General Medicine
Date 2021 Aug 30
PMID 34457305
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

A synchronous tumor represents two histologically distinct neoplasms occurring at the same anatomic site, each displaying a distinct tumorigenesis pathway; they can be primary, secondary, or a mixture. The occurrence of an adenocarcinoma and lymphoma has been reported in gastrointestinal and pulmonary sites; however, such a finding in hepatobiliary system remains elusive. Primary hepatic lymphoma is rare, while primary biliary mucosa-associated lymphoid tissue lymphoma is an even rarer event; hence, its collision with an intrahepatic cholangiocarcinoma could be entirely missed both in practice and in the literature. We herein reported a case of biliary mucosa-associated lymphoid tissue lymphoma occurring synchronously with an intrahepatic cholangiocarcinoma in a 78-year-old female following a biopsy-proven intrahepatic cholangiocarcinoma and hepatectomy. Microscopic examination identified atypical lymphoid population intermingled with this intrahepatic cholangiocarcinoma. An immunohistochemical panel uncovered an incidental mucosa-associated lymphoid tissue lymphoma occurring with this intrahepatic cholangiocarcinoma. This clinically missed entity led to comprehensive systemic investigation/staging, with subsequent detection of bone marrow involvement by stage IV lymphoma. This unique case highlights the importance of astute histomorphological evaluation and thorough ancillary studies in identifying a clinically unsuspected neoplasm in close contact with a known tumor.

Citing Articles

Primary hepatic mucosa-associated lymphoid tissue lymphoma: a case report and literature review.

He T, Zou J Front Oncol. 2024; 14:1430714.

PMID: 39411128 PMC: 11473488. DOI: 10.3389/fonc.2024.1430714.


Primary hepatopancreatobiliary lymphoma: Pathogenesis, diagnosis, and management.

Wang Q, Wu K, Zhang X, Liu Y, Sun Z, Wei S Front Oncol. 2022; 12:951062.

PMID: 36110965 PMC: 9469986. DOI: 10.3389/fonc.2022.951062.

References
1.
Razumilava N, Gores G . Cholangiocarcinoma. Lancet. 2014; 383(9935):2168-79. PMC: 4069226. DOI: 10.1016/S0140-6736(13)61903-0. View

2.
Zinzani P . The many faces of marginal zone lymphoma. Hematology Am Soc Hematol Educ Program. 2012; 2012:426-32. DOI: 10.1182/asheducation-2012.1.426. View

3.
Vogel A, Wege H, Caca K, Nashan B, Neumann U . The diagnosis and treatment of cholangiocarcinoma. Dtsch Arztebl Int. 2014; 111(44):748-54. PMC: 4239580. DOI: 10.3238/arztebl.2014.0748. View

4.
Troch M, Woehrer S, Streubel B, Weissel M, Hoffmann M, Mullauer L . Chronic autoimmune thyroiditis (Hashimoto's thyroiditis) in patients with MALT lymphoma. Ann Oncol. 2008; 19(7):1336-1339. DOI: 10.1093/annonc/mdn049. View

5.
Palmer W, Patel T . Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol. 2012; 57(1):69-76. PMC: 3804834. DOI: 10.1016/j.jhep.2012.02.022. View